Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

3(37.5%)

Phase 4

2(25.0%)

Phase 1

2(25.0%)

N/A

1(12.5%)

8Total

Phase 2(3)

Phase 4(2)

Phase 1(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07064616Not ApplicableRecruiting

Pulsed Field Ablation vs. Cryoballoon Ablation in Patients With Persistent Atrial Fibrillation

Role: lead

NCT04744532Phase 1Unknown

iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study

Role: collaborator

NCT05308329Unknown

Kitasato PCI Registry

Role: lead

NCT04703205Phase 2Unknown

Study in COvid-19 Patients With iveRmectin (CORVETTE-01)

Role: lead

NCT04464681Phase 1Completed

Multiple Dose Escalation Study of M201-A in Healthy Japanese Subjects

Role: lead

NCT04609059Phase 2Unknown

First-in-Patient Study for Sing le Dose of M201-A Hydrochloride Injection in Japanese Patients With Paroxysmal Atrial Fibrillation

Role: lead

NCT00190580Phase 4Completed

Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease

Role: collaborator

NCT00287755Phase 2Completed

Clinical Trial of Chemosensitivity Test

Role: collaborator

NCT00407680Phase 4Unknown

Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

Role: lead

All 9 trials loaded